3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia

Hepato-Gastroenterology

Volumn 50, Issue 50, 2003, Pages 404-407

  Sanz Ortega, Julian ^a   Hernández, Susana ^a   Saez, Maria C ^a   Sierra, Elena ^a   Sanz Ortega, Gonzalo ^a   Torres, Antonio ^a   Balibrea, Jose L ^a   Sanz Esponera, Julian ^a   Merino, Maria J ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Adenocarcinoma; Barrett's esophagus; Loss of heterozygosity; Microdissection

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ALLELE; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 9P; CLINICAL ARTICLE; DISEASE MARKER; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGUS CARCINOMA; FOLLOW UP; GENE DELETION; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SPAIN; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 9; ESOPHAGEAL NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY;

EID: 0037352816     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Geboes K, Van Eyken P: The diagnosis of dysplasia and malignancy in Barrett's oesophagus. Histopathology 2000; 37(2):99-107.
2. Geboes K: Barrett's esophagus: the metaplasia-dysplasia-carcinoma sequence: morphological aspects. Acta Gastroenterol Belg 2000; 63(1):13-17.
3. Van Eyken P: Definition of Barrett's oesophagus. Acta Gastroenterol Belg 2000; 63(1):10-12.
4. Mueller J, Werner M: Malignant progression in Barrett's esophagus: pathology and molecular biology. Recent Results Cancer Res 2000; 155(-HD-):29-41.
5. Galipeau PC, Prevo LJ: Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst 1999; 91(24):2087-2095.
6. Achkar JP, Li HS: Identification of differentially expressed genes in the progression of Barrett's epithelium to esophageal adenocarcinoma. Gastroenterology 1997; 112(4):PA530.
7. Barrett MT, Sanchez CA: Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 1996; 13(9):1867-1883.
8. Barrett MT, Galipeau PC: Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 1996; 12(9):1873-1878.
9. Gonzalez MV, Artimez ML: Mutation analysis of the p53, APC, and p16 genes in the Barrett/s oesophagus, dysplasia, and adenocarcinoma. J Clin Pathol 1997; 50:212-217.
10. Sanz-Ortega J, Sanz-Esponera J: LOH at the APC/MCC gene (5q21) in gastric cancer and preneoplastic lesions. Path Res Pract 1996; 192:1206-1210.
11. Pe'Cina-Slaus N, Paveli'c K: Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas. J Mol Med 1999; 77(5):446-453.
12. Sanz-Ortega J, Bryant B: LOH at the APC/MCC gene is frequent in early stages of NSCLC. Pathol Res Pract 1999; 195:677-680.
13. Ogasawara S, Maesawa C: Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas. Virchows Archiv 1994; 424:607-611.
14. Zhuang Z, Vortmeyer AO: Barrett's esophagus: meta-plastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res 1996; 56:1961-1964.
15. Wang L, Darling J: Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma. Genes Chromosomes Cancer 2000; 27(1): 1-10.
16. Martinez A, Fullwood P: Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis. Mol Pathol 2000; 53(3):137-144.
17. Thiberville L, Payne P: Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res 1995; 55:5133-5139.
18. Kohno H, Hiroshima K: p53 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma: Cancer 1999; 85(2):341-347.
19. Wistuba II, Lam S: Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 1997; 89(18):1366-1373.
20. Mao L, Lee JS: Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 1997; 89(12):857-862.
21. Canzian F, Salovaara R: Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 1996; 56:3331-3337.
22. Dolan K, Garde J: LOH at the sites of the DCC, APC and TP53 tumor suppressor genes occurs in Barrett's metaplasia and dysplasia adjacent to adenocarcinoma of the esophagus. Hum Pathol 1999; 30(12):1508-1514.